Envestnet Asset Management
MGNX icon

Envestnet Asset Management’s MacroGenics MGNX Stock Holding History

Envestnet Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,759
Closed -$106K – 4034
2023
Q1 		$106K Sell
14,759
-20,590
-58% -$124K ﹤0.01% 3789
2022
Q4 		$237K Buy
+35,349
New +$194K ﹤0.01% 3582

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Envestnet Asset Management's MGNX Position: Q2 2023 in Review

Envestnet Asset Management sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 14,759 shares — an estimated $106K sold.

Envestnet Asset Management first reported a position in MGNX in Q4 2022 and held it in 2 quarters. The position peaked at $237K in Q4 2022. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

  • Envestnet Asset Management reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
  • Envestnet Asset Management sold 14,759 MacroGenics shares in Q2 2023, an estimated $106K.
  • Envestnet Asset Management first reported a position in MacroGenics in Q4 2022 and held it in 2 quarters.
  • Envestnet Asset Management's MacroGenics position peaked at $237K in Q4 2022.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on Envestnet Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.